CLINICAL TRIAL

Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin (NECTAR) in Aging and Alzheimer's Disease

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: ClinicalTrials.gov
Date: 2026-08-07
Source: ClinicalTrials.gov
DOI: Unavailable
PubMed: Unavailable

Authors

National Institute on Aging (NIA)

Watch author

Derived topics and classifications

psilocybin Depression Anxiety PTSD Neuroplasticity Brain Imaging Biomarkers Aging Mitochondrial Function Wellbeing Emotional Processing Mystical Experience Clinical Trial Older Adults Safety Adverse Events Inflammation Clinical Trial

Citation graph

0 referenced DOIs found in stored source metadata. 0 indexed papers cite this DOI.

Open citation network

Related papers

Psychedelics, entactogens and psychoplastogens for depression and related disorders.British journal of pharmacology · 2026-07-01 An Examination of Psilocybin Effects on Biomarkers of Longevity, Healthy Aging, and Purpose in LifeClinicalTrials.gov · 2026-08-17 Psychedelics and Psychedelic-Assisted Psychotherapy.The American journal of psychiatry · 2020-05-01 Psychedelics and Psychedelic-Assisted Psychotherapy.Focus (American Psychiatric Publishing) · 2021-01-01